Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



"Cystic fibrosis transmembrane conductance regulator" (CFTR)-genet: mutationer og kliniske faenotyper
Engelsk titel: Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes Läs online Författare: Schwartz M Språk: Dan Antal referenser: 32 Dokumenttyp: Översikt UI-nummer: 03031201

Tidskrift

Ugeskrift for Laeger 2003;165(9)912-6 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Cystic fibrosis (CF) is caused by mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. CF is characterised by chronic lung infections, pancreas insufficiency and, in males, congenital bilateral absence of the vas deferens (CBAVD). Furthermore, mutations in the CFTR are associated with several isolated, CF-related symptoms such as chronic lung diseases, CBAVD idiopathic pancreatitis and asthma. These patients have a higher frequency of CFTR mutations than unaffected individuals. The mutations found are not typical for the CF patients and are classified as mild mutations. One of these mutations (IVS8-5T) is frequently found in patients with the CF-related diseases, and in particular in patients with CBAVD. When a CFTR mutation is identified, genetic counselling and a mutation analysis should be offered to the relevant family members.